Arcutis Biotherapeutics (ARQT) Interest Expenses (2019 - 2026)
Arcutis Biotherapeutics (ARQT) posted quarterly Interest Expenses of $4.4 million for Q1 2026, up 46.67% year-over-year from $3.0 million in Q1 2025, and up 73.23% quarter-over-quarter from $2.5 million in Q4 2025.
Arcutis Biotherapeutics (ARQT) Interest Expenses (2019 - 2026) Analysis & Trends
Arcutis Biotherapeutics' Interest Expenses history runs 8 years deep, the most recent figure standing at $4.4 million for Q1 2026.
- In Q1 2026, Interest Expenses rose 46.67% year-over-year to $4.4 million; the TTM figure through Mar 2026 stood at $13.0 million (down 47.98% YoY), while the FY2025 annual figure was $255.5 million, changed 0.31% from the prior year.
- Interest Expenses for Q1 2026 stood at $4.4 million, up from $2.5 million in the prior quarter.
- The five-year high for Interest Expenses was $40.7 million in Q2 2025, with the low at $1.8 million in Q1 2022.
- The 5-year median for Interest Expenses is $6.7 million (2024), against an average of $7.4 million.
- The sharpest annual moves came in 2022 and 2025: Interest Expenses soared 3320.18% in 2022, then sank 67.91% in 2025.
- Arcutis Biotherapeutics' Interest Expenses stood at $3.9 million in 2022, then jumped by 99.08% to $7.8 million in 2023, then climbed by 1.97% to $7.9 million in 2024, then tumbled by 67.91% to $2.5 million in 2025, then jumped by 73.23% to $4.4 million in 2026.
- Business Quant data shows ARQT's Interest Expenses at $4.4 million in Q1 2026, $2.5 million in Q4 2025, and $3.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Arcutis Biotherapeutics | 3.29 Bn | 3.05 Bn | 118.92 Mn | 101.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 101.67 Mn |
| Jun 30, 2026 | 101.67 Mn |
| Mar 31, 2026 | 4.40 Mn |
| Mar 31, 2026 | 4.40 Mn |
| Dec 31, 2025 | 2.54 Mn |
| Dec 31, 2025 | 2.54 Mn |
| Sep 30, 2025 | 3.10 Mn |
| Sep 30, 2025 | 3.10 Mn |
| Jun 30, 2025 | 40.75 Mn |
| Jun 30, 2025 | 40.75 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Dec 31, 2024 | 7.92 Mn |
| Dec 31, 2024 | 7.92 Mn |
| Sep 30, 2024 | 6.65 Mn |
| Sep 30, 2024 | 6.65 Mn |
| Jun 30, 2024 | 7.50 Mn |
| Jun 30, 2024 | 7.50 Mn |
| Mar 31, 2024 | 7.50 Mn |
| Mar 31, 2024 | 7.50 Mn |